产品中心PRODUCT CENTER
全国热线：027-87561633
| 位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M |
| A1,B1 | 50 | F | 乳腺 | 正常 | / | / | / | / |
| A2,B2 | 43 | F | 乳腺 | 正常 | / | / | / | / |
| A3,B3 | 50 | F | 乳腺 | 正常 | / | / | / | / |
| A4,B4 | 30 | F | 乳腺 | 增生 | / | / | / | / |
| A5,B5 | 52 | F | 乳腺 | 增生 | / | / | / | / |
| A6,B6 | 38 | F | 乳腺 | 增生 | / | / | / | / |
| A7,B7 | 41 | F | 乳腺 | 增生 | / | / | / | / |
| A8,B8 | 40 | F | 乳腺 | 乳腺纤维囊性病 | / | / | / | / |
| A9,B9 | 41 | F | 乳腺 | 乳腺纤维囊性病 | / | / | / | / |
| A10,B10 | 39 | F | 乳腺 | 纤维腺瘤 | / | / | / | / |
| A11,B11 | 16 | F | 乳腺 | 纤维腺瘤 | / | / | / | / |
| A12,B12 | 34 | F | 乳腺 | 纤维腺瘤 | / | / | / | / |
| C1,D1 | 38 | F | 乳腺 | 叶状囊肉瘤 | / | Tis | N0 | M0 |
| C2,D2 | 52 | F | 乳腺 | 导管内癌 | I | Tis | N0 | M0 |
| C3,D3 | 33 | F | 乳腺 | 导管内癌 | I | Tis | N0 | M0 |
| C4,D4 | 37 | F | 乳腺 | 导管内癌 | I~II | T3 | N1 | M1 |
| C5,D5 | 53 | F | 乳腺 | 导管内癌 | I | Tis | N0 | M0 |
| C6,D6 | 61 | M | 乳腺 | 浸润性导管癌 | I~II | T2 | N0 | M0 |
| C7,D7 | 41 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C8,D8 | 55 | F | 乳腺 | 浸润性导管癌 | III | T3 | N2 | M0 |
| C9,D9 | 44 | F | 乳腺 | 浸润性导管癌 | II~III | T3 | N0 | M0 |
| C10,D10 | 72 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| C11,D11 | 41 | F | 乳腺 | 浸润性导管癌 | II | T3 | N2 | M0 |
| C12,D12 | 18 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| E1,F1 | 31 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| E2,F2 | 54 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| E3,F3 | 75 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
| E4,F4 | 30 | F | 乳腺 | 浸润性导管癌 | I~II | T3 | N0 | M0 |
| E5,F5 | 43 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
| E6,F6 | 37 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| E7,F7 | 42 | F | 乳腺 | 浸润性导管癌 | II~III | T4 | N2 | MX |
| E8,F8 | 30 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
| E9,F9 | 39 | F | 乳腺 | 浸润性导管癌 | I~II | T3 | N0 | M0 |
| E10,F10 | 46 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| E11,F11 | 40 | F | 乳腺 | 浸润性导管癌 | II | T3 | N1 | M0 |
| E12,F12 | 58 | F | 乳腺 | 浸润性导管癌 | II | T3 | N0 | M0 |
| G1,H1 | 35 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
| G2,H2 | 53 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| G3,H3 | 50 | F | 乳腺 | 浸润性导管癌 | II~III | T4 | N3 | M1 |
| G4,H4 | 48 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
| G5,H5 | 51 | F | 乳腺 | 浸润性导管癌 | II | T3 | N1 | M0 |
| G6,H6 | 43 | F | 乳腺 | 浸润性导管癌 | II~III | T4 | N2 | MX |
| G7,H7 | 43 | F | 乳腺 | 浸润性导管癌 | II~III | T3 | N1 | M0 |
| G8,H8 | 40 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
| G9,H9 | 47 | F | 乳腺 | 浸润性导管癌 | III | T3 | N1 | M0 |
| G10,H10 | 49 | F | 乳腺 | 浸润性导管癌 | II~III | T3 | N1 | M0 |
| G11,H11 | 58 | F | 乳腺 | 浸润性导管癌 | / | T3 | N2 | M0 |
| G12,H12 | 40 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
027-87561633
121545059@qq.com
武汉东湖新技术开发区高新大道666号光谷生物城生物创新园B1栋b274-9室